Jalna co awaits Govt nod for field trials of anti-dengue tech

Image
Press Trust of India Jalna
Last Updated : Jan 22 2016 | 1:57 AM IST
A local private firm is awaiting the Government's permission to conduct field trials of a breakthrough technology that is aimed at controlling population of 'Aedes aegypti', the female mosquito responsible for transmitting dengue and chikungunya.
Jalna-based Gangabishan Bhikulal Investment and Trading (GBIT) is testing the technology, developed by British company Oxitec, which can eliminate 'Aedes aegypti' through generically-modified (GM) male mosquito.
Shaibal Dasgupta, a top scientist with GBIT, claimed that when the OX513A, a genetically engineered male mosquito, mates its female counterpart, the gene is passed on to the offspring, which do not survive beyond the larva stage'.
The progeny does not survive till adulthood and they die a natural death which helps in controlling the mosquito- transmitted diseases over a period of time, he said.
GBIT is awaiting Government's permission to conduct field trials of this technology, which has already been released in Brazil and is at an advance stage of approval in other countries, Dasgupta said.
He said GBIT is optimistic the Government will provide an enabling environment for its eventual release in India.
The company said the genetically engineered male mosquito will suppress the mosquito population to a level at which it cannot spread diseases.
This technology is not only environment-friendly but also effective in controlling the rising health menace caused by mosquitoes, Dasgupta said.
According to a WHO report, every year 7,25,000 people are affected by mosquito-borne diseases globally and a large number of people die due to dengue in India. Hence, this technology assumes a greater importance for our country, he added.
According to GBIT's website, the company is investing in and incubating novel ideas related to human health and agriculture. It is founded by Badrinarayan Barwale, who set up Maharashtra Hybrid Seeds Company Ltd (MAHYCO) - a pioneer in high quality production of hybrid/open-pollinated seeds.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 22 2016 | 1:57 AM IST

Next Story